The epidemiological profile and correlation between blood hemoglobin levels and hemodialysis duration in twice-week hemodialysis patients

Dedi Ardinata; Mutiara Indah Sari; Milahayati Daulay

doi:10.53730/ijhs.v6nS5.8122

Authors

Dedi Ardinata
dedi1@usu.ac.id
Department of Physiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Mutiara Indah Sari Department of Biochemistry, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Milahayati Daulay Department of Physiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

Keywords:

blood, hemoglobin, hemodialysis patients

Abstract

A cross-sectional study was carried out at the H. Adam Malik hospital in Medan. Purposive sampling was used to identify 55 research patients receiving hemodialysis (HD). Structured questionnaire interviews with patients were used to collect epidemiology data. Medical records and retested laboratory results were used to collect data on hemoglobin, qualitative C Reactive Protein (CRP), Blood urea nitrogen (BUN), and creatinine. The majority (72.7 %) of participants were male, with the 60–69 year age group accounting for 30.90%; Karo is the most ethnic group (41.8%), and hypertension is the most prevalent ailment (43.60%). The mean duration of HD was 36.00 months, with a hemoglobin (Hb) level of 9.37 g/dl. It can be shown that there is a negative and weak correlation between Hb and HD duration (r = -0.27) that is significant (p = 0.49) and has a coefficient of determination of 7%.

Downloads

Download data is not yet available.

References

Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney International Supplements 2013; 3: 368–371.

Lew QLJ, Allen JC, Nguyen F, et al. Factors Associated with Chronic Kidney Disease and Their Clinical Utility in Primary Care Clinics in a Multi-Ethnic Southeast Asian Population. Nephron 2018; 138: 202–213.

Wu HY, Huang JW, Peng Y Sen, et al. Microalbuminuria screening for detecting chronic kidney disease in the general population: A systematic review. Renal Failure 2013; 35: 607–614.

Fehr T, Ammann P, Garzoni D, et al. Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia. Kidney International 2004; 66: 1206–1211.

Lau BCV, Ong KY, Yap CW, et al. Predictors of anemia in a multi-ethnic chronic kidney disease population: a case–control study. SpringerPlus 2015; 4: 1–9.

Stauffer ME, Fan T. Data from the National Health and Nutrition Examination Survey (NHANES) Citation: Stauffer ME, Fan T (2014) Prevalence of Anemia in Chronic Kidney Disease in the United States. PLoS ONE 2007; 9: 84943.

Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International Supplements 2012; 2: 279–335.

Babitt JL, Lin HY. Mechanisms of anemia in CKD. Journal of the American Society of Nephrology 2012; 23: 1631–1634.

Crawford PW, Lerma E V. Treatment Options for End Stage Renal Disease. Primary Care - Clinics in Office Practice 2008; 35: 407–432.

Fleming GM. Renal replacement therapy review. Organogenesis 2011; 7: 2–12.

KOLFF WJ, BERK HTJ, WELLE NM, et al. The Artificial Kidney: a dialyser with a great area. Acta Medica Scandinavica 1944; 117: 121–134.

Himmelfarb J, Ikizler TA. Hemodialysis. New England Journal of Medicine 2010; 363: 1833–1845.

Zyga S, Sarafis P. Haemodialysis adequacy - Contemporary trends. Health Science Journal 2009; 3: 209–215.

Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney International 2006; 70: 1694–1705.

Tjang YS, Anung P, Pandelaki A. Factors Associated with Chronic Kidney Disease Among Patients Undergoing Hemodialysis. 167–170.

Indonesian P, Registry R, Course H. 10 th Report Of Indonesian Renal Registry 2017 10 th Report Of Indonesian Renal Registry 2017.

Silbiger S, Neugarten J. Gender and human chronic renal disease. Gender Medicine 2008; 5: 3–10.

Weinstein JR, Anderson S. The Aging Kidney: Physiological Changes. Advances in Chronic Kidney Disease 2010; 17: 302–307.

Hill NR, Fatoba ST, Oke JL, et al. Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis. 2016; 1–18.

Meuwese CL, Carrero JJ. Chronic kidney disease and hypothalamic-pituitary axis dysfunction: The chicken or the egg? Archives of Medical Research 2013; 44: 591–600.

Stringer KD, Komers R, Osman SA, et al. Gender hormones and the progression of experimental polycystic kidney disease. Kidney International 2005; 68: 1729–1739.

Cobo G, Hecking M, Port FK, et al. Sex and gender differences in chronic kidney disease: Progression to end-stage renal disease and haemodialysis. Clinical Science 2016; 130: 1147–1163.

Van Buren PN, Inrig JK. Hypertension and hemodialysis: Pathophysiology and outcomes in adult and pediatric populations. Pediatric Nephrology 2012; 27: 339–350.

Whaley-Connell AT, Sowers JR, Stevens LA, et al. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. American Journal of Kidney Diseases 2008; 51: 1999–2004.

Delima D, Tjitra E. Faktor Risiko Penyakit Ginjal Kronik : Studi Kasus Kontrol di Empat Rumah Sakit di Jakarta Tahun 2014. Buletin Penelitian Kesehatan. Epub ahead of print 2017. DOI: 10.22435/bpk.v45i1.7328.17-26.

Pongsibidang GS. Risiko Hipertensi, Diabetes, Dan Konsumsi Minuman Herbal Pada Kejadian Gagal Ginjal Kronik Di Rsup Dr Wahidin Sudirohusodo Makassar Tahun 2015. Jurnal Wiyata Penelitian Sains dan Kesehatan.

Skov J, Christiansen JS, Poulsen PL. Hypertension and diabetic nephropathy. Endocrine Development 2016; 31: 97–107.

Karaboyas A, Morgenstern H, Waechter S, et al. Low hemoglobin at hemodialysis initiation: an international study of anemia management and mortality in the early dialysis period. Clinical Kidney Journal 2019; 1–9.

Mohammadi P, Jalilian FA, Ahmadinia H, et al. Correlation between blood lead level and anemia in hemodialysis patients. Journal of Renal Injury Prevention 2021; 10: 1–6.